Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 17-AAG | 0.01 | uM | 8 | 2500.00 | 1955.17 | 2888.00 | 4404.75 | 0.6557 | 0.3950 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 8 | 2500.00 | 1955.17 | 2872.00 | 4404.75 | 0.6520 | 0.3884 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 8 | 2500.00 | 1955.17 | 3818.00 | 4404.75 | 0.8668 | 0.7703 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 8 | 2500.00 | 1955.17 | 1941.00 | 4404.75 | 0.4407 | -0.0062 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 8 | 2500.00 | 1955.17 | 4220.00 | 4404.75 | 0.9581 | 0.9282 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 8 | 2500.00 | 1955.17 | 3718.00 | 4404.75 | 0.8441 | 0.7307 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 8 | 2500.00 | 1955.17 | 4248.00 | 4404.75 | 0.9644 | 0.9391 |
| SK-BR-3 | Lapatinib | 1 | uM | 8 | 2500.00 | 1955.17 | 2087.00 | 4404.75 | 0.4738 | 0.0573 |
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 4376.00 | 4404.75 | 0.9935 | 0.9889 | |
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 4055.00 | 4404.75 | 0.9206 | 0.8637 | |
| SK-BR-3 | 0 | uM | 8 | 5000.00 | 1743.19 | 6135.00 | 6349.75 | 0.9662 | 0.9634 | |
| SK-BR-3 | 0 | uM | 8 | 5000.00 | 1743.19 | 6337.00 | 6349.75 | 0.9980 | 0.9979 | |
| SK-BR-3 | Linsitinib | 0.1 | uM | 8 | 5000.00 | 1743.19 | 6311.00 | 6349.75 | 0.9939 | 0.9935 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 8 | 5000.00 | 1743.19 | 4043.00 | 6349.75 | 0.6367 | 0.5700 |
| SK-BR-3 | Linsitinib | 10 | uM | 8 | 5000.00 | 1743.19 | 5001.00 | 6349.75 | 0.7876 | 0.7597 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 8 | 5000.00 | 1743.19 | 6152.00 | 6349.75 | 0.9689 | 0.9664 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 8 | 5000.00 | 1743.19 | 3405.00 | 6349.75 | 0.5362 | 0.4319 |
| SK-BR-3 | Erlotinib | 1 | uM | 8 | 5000.00 | 1743.19 | 6013.00 | 6349.75 | 0.9470 | 0.9424 |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 8 | 5000.00 | 1743.19 | 6337.00 | 6349.75 | 0.9980 | 0.9979 |
| SK-BR-3 | 0 | uM | 8 | 5000.00 | 1743.19 | 6509.00 | 6349.75 | 1.0251 | 1.0267 | |
| SK-BR-3 | Linsitinib | 1 | uM | 8 | 5000.00 | 1743.19 | 5899.00 | 6349.75 | 0.9290 | 0.9226 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 8 | 5000.00 | 1743.19 | 6391.00 | 6349.75 | 1.0065 | 1.0070 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 8 | 5000.00 | 1743.19 | 3994.00 | 6349.75 | 0.6290 | 0.5598 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 8 | 5000.00 | 1743.19 | 6363.00 | 6349.75 | 1.0021 | 1.0022 |
| SK-BR-3 | 0 | uM | 8 | 5000.00 | 1743.19 | 6476.00 | 6349.75 | 1.0199 | 1.0212 |